Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep15 | Adrenal and Cardiovascular Endocrinology | ECE2020

Multiple hormonal deficiency in heart failure with preserved ejection fraction: Prevalence and role in modulation of antioxidant levels and myocardial dysfunction indexes

Bruno Carmine , Vergani Edoardo , Calarco Rodolfo , Anna Nicolazzi Maria , Maria Rita Favuzzi Angela , d’Abate Claudia , Silvestrini Andrea , Meucci Elisabetta , Mordente Alvaro , Mancini Antonio

In heart failure with reduced ejection fraction, catabolic mechanisms have a strong negative impact on mortality and morbidity. The relationship between anabolic hormonal deficiency and heart failure with preserved ejection fraction (HFpEF) has still been poorly investigated. On the other hand, oxidative stress is recognized as a player in the pathogenesis of HFpEF. Therefore, we performed a cohort study in HFpEF in order to: 1) define the multi-hormonal deficiency prevalence ...

ea0031s2.1 | Hormone Maketh Man | SFEBES2013

Anti-Mullerian hormone: a Sertoli cell hormone that can be used as a predictor of male hypogonadism

Rey Rodolfo

Sertoli cells are the most active cell population in the prepubertal testis. During infancy and childhood, male hypogonadism can be evidenced by assessing Sertoli cell function without the need for stimulation tests. Anti-Müllerian hormone (AMH) is a distinctive serum marker of the prepubertal Sertoli cell, which is high from foetal life until puberty. AMH production is stimulated by FSH and potently inhibited by androgens. Initially used only to distinguish between patie...

ea0049ep548 | Diabetes complications | ECE2017

Diabetic ketoacidosis in an intensive care unit – review

Oliveira Joana , Gomes Rodolfo , Picado Barbara , Goncalves Fernando , Araujo Jose

Diabetic ketoacidosis (DK) is one of the most serious complications of diabetes mellitus (DM). We performed a case review of DK patients admitted to the intensive care unit (ICU) of our Hospital between 1 June 2012 and 30 June 2016. A demographic analysis was made, time of DM evolution, the therapy and the factors that led to its decompensation. Thus, a total of 42 DK patients were admitted to the ICU in the referred period, mean age was 45 years, a clear predominance of femal...

ea0049ep573 | Diabetes complications | ECE2017

Two case reports of diabetic ketoacidosis: as lethal as avoidable

Gomes Rodolfo , Oliveira Joana , Picado Barbara , Goncalves Fernando , Araujo Jose

Diabetic ketoacidosis (DKA) is one of the most serious complications of diabetes mellitus (DM). We describe 2 cases of type-2 diabetic patients admitted by a surgical reason/trauma in which DM control was neglected. We present a 74-year-old patient with poor metabolic control (HbA1c 7,6%) treated with metphormin, sitagliptin and glibenclamide, admitted for orthopaedic surgery. During hospitalization, there were noted several episodes of disorientation with hyperglycae...

ea0090ep707 | Pituitary and Neuroendocrinology | ECE2023

Safety and efficacy of once weekly somapacitan versus once daily growth hormone among adults with growth hormone deficiency: A systematic review and meta-analysis

Co Faith Abigail , Baliclic Micah Fiel , Sese Kevin , Pagcatipunan Jr. Rodolfo S

Background: Adult growth hormone deficiency (AGHD) has been increasingly observed among patients with traumatic brain injury, stroke, and central nervous system infection, aside from the subgroup of patients with pituitary tumors. When left untreated, these patients have a significantly increased risk to develop cardiovascular morbidity and mortality and impaired psychosocial function. Existing treatment guidelines on AGHD have recommended the use of growth hormone (GH) replac...

ea0049ep1461 | Thyroid (non-cancer) | ECE2017

Is thyroglobulin at ablation a good predictor of the thyroid remnant size in differentiated thyroid cancer?

Martins Helder , Costa Gracinda , Isidoro Jorge , Gil Paulo , Silva Rodolfo , de Lima Joao Pedroso

Aim: Stimulated thyroglobulin (sTg), measured at radioiodine remnant-ablation (RRA) in patients with differentiated thyroid cancer(DTC), is an important predictive factor of persistent disease. However, Tg produced by normal thyroid cells may also contribute to the sTg value.We aimed to study the relationship between sTg-level in RRA and the thyroid remnant size (TRs), using post-therapy whole-body scan (131I-ptWBS), at different TSH stimulation method.<...

ea0099p506 | Endocrine-Related Cancer | ECE2024

Primary hyperparathyroidism due to parathyroid cancer or atypical adenoma. a third-level spanish hospital experience

Malo Carolina Sanchez , Remigio Roberto Carlos Romo , Martin Salvago Maria Dolores Maria , Sendra Rodolfo Gonzalez , Garrido Maria Carmen Rosa

Parathyroid carcinoma (PC) is very rare and difficult to differentiate from atypical parathyroid adenoma (AA). En-bloc surgical resection is recommended, but most cases are diagnosed after non-radical surgery, and it is recommended to expand it. Given the rarity of the cases, the difficulty in the histological diagnosis (HD) and the unpredictability of the evolution, we analyzed our experience with PC and AA.Material and methods: We conducted a ...

ea0099ep1112 | Pituitary and Neuroendocrinology | ECE2024

Acromegaly in humans, cats and dogs: epidemiological, pathophysiological, clinical and management resemblances and differences

Lopes-Pinto Mariana , Lunet Marques Patricia , Paula Ricca Lacerda Nobre M Caetano Ema , Miceli Diego , Oliveira Leal Rodolfo , Marques Pedro

Background: Acromegaly is a rare disorder associated with excessive levels of growth hormone(GH) and insulin-like growth factor-1(IGF-1). GH/IGF-1 excess leads to morphologic craniofacial and acral changes as well as cardiometabolic complications, but the phenotypic changes and presentation differ across species.Aim: To present the resemblances and distinctive features of acromegaly in humans, cats and dogs.Methods: A literature re...

ea0089c15 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2022

Effectiveness and Safety of Re-Treatment With 177Lu-DOTATATE in Patients With Progressive NETs in the US: a Retrospective Real-World Study

Delpassand Ebrahim , Mohammadi Yazdi Soheil , Ghantoji Shashank , Reis Nakasato Antonio , Denise Strickland Corinne , Nunez Rodolfo , Shafie Afshin , Cork Susan , Byrne Clare , Tang Jackson , Runeckles Kyle , Patel Jeetvan

Background: Advanced neuroendocrine tumors (NETs) are associated with poor prognoses. A 4-dose regimen of lutetium Lu 177 (177Lu)-DOTATATE has been shown to improve progression-free survival (PFS) and overall survival (OS) in patients with advanced NETs. This is the first United States (US) study to evaluate the effectiveness and safety of additional doses in patients with progressive NETs.Methods: This was a retrospective chart review of 31 a...

ea0049oc6.2 | Diabetes therapy and complications | ECE2017

Insulin-mimetic effects of short-term Rapamycin in type 1 diabetic patients prior islet transplantation

Ermetici Federica , Briganti Silvia , Benedini Stefano , Codella Roberto , Maffi Paola , Caldara Rossana , Secchi Antonio , Piemonti Lorenzo , Alejandro Rodolfo , Ricordi Camillo , Luzi Livio

It has been suggested that the selective m-TOR inhibitor, Rapamycin, has been improved the success pancreatic islet allotransplantation (ITx) in type 1 diabetic patients (T1DM). Forty-one ITx were studied. Thirteen T1DM in poor glycemic control underwent a 45-days Rapamycin before ITx followed by standard Edmonton Protocol (EP, group 1, Milan), and they were compared to 28 T1DM patients undergoing EP (group 2, Miami). Outcome measures were daily insulin requirement (DIR), HbA1...